Pharma M&A is an absolute seller’s market: Alpesh Dalal of Lupin

By Ishaan Gera

  • 17 Nov 2015
Premium

Lupin Ltd, India's second largest drugmaker by market value, had been pursuing inorganic expansion during 2007-11, but had gone quiet on the mergers and acquisitions (M&A) front since then. Early last year, it revived its M&A-led growth strategy and since then has signed half a dozen deals. In July, it ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.